Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue SarcomaMrinal M. Gounder, Albiruni Ryan Abdul Razak, Mark A. Dickson et al.|Journal of Clinical Oncology|2016Cited by 165
Augmenting advance care planning in poor prognosis cancer with a video decision aidAngelo E. Volandes, Ariela Noy, Tomer T. Levin et al.|Cancer|2012Cited by 79